PROTECTIVE EFFECTS OF A NOVEL 32-AMINO ACID C-TERMINAL FRAGMENT OF CAP18 IN ENDOTOXEMIC PIGS

被引:22
作者
VANDERMEER, TJ
MENCONI, MJ
ZHUANG, J
WANG, HL
MURTAUGH, R
BOUZA, C
STEVENS, P
FINK, MP
机构
[1] BETH ISRAEL HOSP,DEPT SURG,BOSTON,MA 02215
[2] BETH ISRAEL HOSP,DEPT ANESTHESIOL,BOSTON,MA 02215
[3] HARVARD UNIV,SCH MED,BOSTON,MA
[4] TUFTS UNIV,SCH VET MED,DEPT MED,N GRAFTON,MA 01536
[5] AMGEN INC,THOUSAND OAKS,CA 91320
关键词
D O I
10.1016/S0039-6060(95)80009-3
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Cationic antimicrobial protein of 18 kd (CAP18) is a neutrophil-derived peptide that binds lipopolysaccharide (LPS) with high affinity. We hypothesized that CAP18(106-137), a novel synthetic 32-amino acid C-terminal fragment of CAP18, would neutralize the physiologic derangements induced by LPS in anesthetized swine. Methods. Pigs were randomly allocated into three groups. Those in the LPS group (n = 6) were infused with LPS (3 mu g/kg/hr for 3 hours). Pigs in the LPS/CAP18 group (n = 6) were challenged with LPS (3 mu g/kg/hr for 4 hours) and also treated with CAP18(106-137) (4 mg/kg/hr for 4 hours). Pigs in the RL group (n = 4) received neither LPS nor CAP18(106-137). Results. Treatment with CAP18(106-137) blocked LPS-induced increases in plasma levels of 6-keto-prostaglandin F1 alpha and tumor necrosis factor-alpha and prevented LPS-induced changes in cardiac output, arterial PO2, phagocyte activation, and peripheral leukocyte count. Changes in circulating concentrations of thromboxane B-2, mean pulmonary artery pressure, and dynamic pulmonary compliance were attenuated in the LPS//CAP18 group. Conclusions. Treatment with CAP18(106-137) neutralizes many of the deleterious effects of LPS in pigs.
引用
收藏
页码:656 / 662
页数:7
相关论文
共 23 条
[1]  
Suffredini, Fromm, Parker, Et al., The cardiovascular response of normal humans to administration of endotoxin, N Engl J Med, 321, pp. 280-287, (1989)
[2]  
Danner, Elin, Hosseini, Wesley, Reilly, Parrillo, Endotoxemia in human septic shock, Chest, 99, pp. 169-175, (1991)
[3]  
Van Deventer, Buller, ten Cate, Sturk, Pauw, Endotoxaemia: an early predictor of septicaemia in febrile patients, Lancet, 1, pp. 605-609, (1988)
[4]  
Parsons, Worthen, Moore, Tate, Henson, The association of circulating endotoxin with the development of the adult respiratory distress syndrome, Am Rev Respir Dis, 140, pp. 294-301, (1989)
[5]  
VanderMeer, Menconi, O'Sullivan, Et al., Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia, J Appl Physiol, 76, pp. 2006-2014, (1994)
[6]  
Priest, Brinson, Schroeder, Dunn, Treatment of experimental gram-negative bacterial sepsis with murine monoclonal antibodies directed against lipopolysaccharide, Surgery, 106, pp. 147-155, (1989)
[7]  
Ziegler, Douglas, Sherman, Davis, Braude, Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-Gal epimerase-deficient mutant, J Immunol, 111, pp. 433-438, (1973)
[8]  
Alpert, Baldwin, Thompson, Et al., Limulus antilipopolysaccharide factor protects rabbits from meningococcal endotoxin shock, J Infect Dis, 165, pp. 494-500, (1992)
[9]  
Flynn, Shenep, Stokes, Fairclough, Hildner, Polymyxin B moderates acidosis and hypotension in established experimental gram-negative septicemia, J Infect Dis, 156, pp. 706-712, (1987)
[10]  
Greenman, Schein, Martin, Et al., A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis, JAMA, 266, pp. 1097-1102, (1991)